STAT Plus: Why do ‘never smokers’ get lung cancer? In some cases, rare genetic variant may be a factor STAT 19:10
STAT Plus: Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and more STAT 13:04
STAT Plus: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal STAT 08:50
STAT Plus: GOP aims to change Medicare adviser’s math to help out private insurers STAT 21:25 Wed, 16 Sep
STAT Plus: Senators highlight the power Chris Klomp wields at confirmation hearings STAT 20:26 Wed, 16 Sep
STAT Plus: Scientists made mice with half a brain. Then they filled them with human organoids STAT 16:04 Wed, 16 Sep
STAT Plus: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more STAT 14:42 Wed, 16 Sep
STAT Plus: Sen. Warren demands to see Trump drug-pricing pharma contracts, accuses RFK Jr. of hiding them STAT 14:38 Wed, 16 Sep
STAT Plus: House Democrats may use oversight powers to plan for health care overhaul STAT 09:35 Wed, 16 Sep
STAT Plus: FDA takes applications for new program to shorten drug approval times STAT 15:05 Tue, 15 Sep
STAT Plus: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more STAT 14:38 Tue, 15 Sep
STAT Plus: Vera kidney drug Trutakna shows strong final results in Phase 3 trial STAT 11:37 Tue, 15 Sep
STAT Plus: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more STAT 14:13 Mon, 14 Sep
STAT Plus: Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggests STAT 23:34 Sun, 13 Sep
STAT Plus: Pharma wins a battle over the cost of wastewater treatment in Europe STAT 08:17 Sat, 12 Sep
STAT Plus: Scholar Rock wins FDA approval for first drug to target SMA muscle loss STAT 00:41 Sat, 12 Sep
STAT Plus: Pharmalittle: We’re reading about anxious Novartis investors, patent expirations for biologics, and more STAT 15:00 Fri, 11 Sep
STAT Plus: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field STAT 09:36 Fri, 11 Sep
STAT Plus: Right before midterms, Trump dangles $500 refunds for select ACA enrollees STAT 21:06 Thu, 10 Sep
STAT Plus: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more STAT 14:15 Thu, 10 Sep
STAT Plus: Cancer medicines remain in short supply across the U.S., survey finds STAT 14:15 Thu, 10 Sep
STAT Plus: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon STAT 11:34 Thu, 10 Sep